Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 65
- Pharmaceutical
Agreements to advance chronic pain relief for trigeminal neuralgia
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
- Cultivation
Release of exclusive hybrid cannabis seeds by Royal Queen Seeds Pro
Royal Queen Seeds Pro believes F1 hybrid seeds are the future of cannabis growing.
- Cultivation
What makes hemp such a sustainable crop?
Canxchange looks at how hemp can be a big part of solving the most pressing challenges facing our environment.
- CBD Market
SEED Innovations makes investment in CBD brand company
Focusing on making investments in the medical cannabis, health and wellness spaces, Guernsey-based SEED Innovations has invested £150,000 in South West Brands Limited.
- CBD Market
Yooma Wellness diversifies portfolio with Japanese acquisition
Yooma Wellness has acquired the Japanese Wellness brand Vertex Co. for US$12,000,000.
- Cultivation
Adapting to growth in the medical cannabis market
Aleiya Lonsdale, head of marketing at Lab Innovations 2021, looks at why labs will need to become more adaptable to the expected growth in the market.
- Companies
CanCoin announces KingSwap listing date
The CanCoin will list on KingSwap DEX on 5 October using the ticker $CANNA.
- CBD Market
Avida Global acquires Canna Creations and Green Stem CBD
Avida Global will be a fully vertically integrated seed-to-sale business thanks to its new acquisition of Canna Creations and Green Stem CBD.
- CBD Market
Analysis shows 90 per cent of CBD brands third-party test products
A new analysis of CBD product testing has shown that 90 per cent of brands third-party test their products.
- Medical
MGC Pharmaceuticals fast-tracks CimetrA US sales with AMC order
MGC Pharma has signed a Supply and Distribution Agreement with AMC Holdings.
- Policy & Regulation
Transforming London’s cannabis expertise into a world-leading industry
In this article, Hamish Stewart, Chair of the London Cannabis Legalisation Commission, explores three steps London can take to transform its medical cannabis expertise into a world-leading industry.
- Policy & Regulation
Amazon to lobby US government for federal cannabis legalisation
Amazon is supporting cannabis reform in the US as part of its advocacy for equitable workplaces.
